Biotech announced that it recently received two revenue-related government grants totaling 29 million yuan. The company recognizes it as a government subsidy related to revenue in accordance with relevant accounting standards, which is expected to have a positive impact on profit and loss in 2025. However, the subsidy has not been audited, and the specific accounting treatment and impact on profit and loss are based on the results confirmed by the auditing agency's annual audit.

Biotech announced that it recently received two revenue-related government grants totaling 29 million yuan. The company recognizes it as a government subsidy related to revenue in accordance with relevant accounting standards, which is expected to have a positive impact on profit and loss in 2025. However, the subsidy has not been audited, and the specific accounting treatment and impact on profit and loss are based on the results confirmed by the auditing agency's annual audit.